Current practices of HBV evaluation and monitoring in HIV/HBV co-infected patients

被引：0
|
作者：
Opio, CK
Pillai, R
Lee, W
Keiser, P
Jain, MK
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A701 / A701
页数：1
相关论文
共 50 条
  • [21] Skin cancer in patients who are co-infected with HIV/ HBV or HIV/HCV: a systematic review
    Woori Lee
    Daniel K. Cho
    Sara D. Ragi
    Amor Khachemoune
    Archives of Dermatological Research, 317 (1)
  • [22] High HBV Viral Load is associated with Mixed HBV Genotypes and Liver Stiffness in Co-infected HIV Mexican Patients
    Roman, Sonia
    Jose-Abrego, Alexis
    Gonzalez-Aldaco, Karina
    Alberto Torres-Reyes, Luis
    Ojeda-Granados, Claudia
    Panduro, Arturo
    HEPATOLOGY, 2017, 66 : 1029A - 1029A
  • [23] Tenofovir disoproxil fumarate (TDF) suppresses lamivudine-resistant HBV replication in patients co-infected with HIV/HBV
    Benhamou, Y
    Bochet, M
    Tubiana, R
    Thibault, V
    Suffisseau, L
    Sullivan, M
    Rooney, J
    Brosgart, C
    Bricaire, F
    Katlama, C
    Poynard, T
    JOURNAL OF HEPATOLOGY, 2002, 36 : 138 - 138
  • [24] TREAMENT-INDUCED AND VACCINE ESCAPE HBV MUTANTS IN HIV-HBV CO-INFECTED PATIENTS: A LONGITUDINAL ANALYSIS
    Lacombe, Karine
    Boyd, Anders
    Lavocat, Fabien
    Gozlan, Joel
    Miailhes, Patrick
    Bonnard, Philippe
    Lascouxcombe, Caroline
    Vernet, Guy
    Girard, Pierre-Marie
    Zoulim, Fabien
    HEPATOLOGY, 2009, 50 (04) : 407A - 407A
  • [25] Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in the Gambia, West Africa
    Stewart B.
    Jobarteh M.L.
    Sarge-Njie R.
    Alabi A.
    De Silva T.
    Peterson K.
    Peterson I.
    Whittle H.
    Rowland-Jones S.
    Jaye A.
    Cotten M.
    Mendy M.
    BMC Research Notes, 4 (1)
  • [26] HBV transcription and translation persist despite viral suppression in HBV-HIV co-infected patients on antiretroviral therapy
    Lisker-Melman, Mauricio
    Wahed, Abdus S.
    Ghany, Marc G.
    Chung, Raymond T.
    King, Wendy C.
    Kleiner, David E.
    Bhan, Atul K.
    Khalili, Mandana
    Jain, Mamta K.
    Sulkowski, Mark
    Wong, David K.
    Cloherty, Gavin
    Sterling, Richard K.
    HEPATOLOGY, 2023, 77 (02) : 594 - 605
  • [27] Incidence of Liver Damage of Uncertain Origin in HIV Patients Not Co-Infected with HCV/HBV
    Rivero-Juarez, Antonio
    Camacho, Angela
    Merchante, Nicolas
    Perez-Camacho, Ines
    Macias, Juan
    Ortiz-Garcia, Carmen
    Cifuentes, Celia
    Torre-Cisneros, Julian
    Pena, Jose
    Pineda, Juan A.
    Rivero, Antonio
    PLOS ONE, 2013, 8 (07):
  • [28] Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients
    Bottero, Julie
    Lacombe, Karine
    Guechot, Jerome
    Serfaty, Lawrence
    Miailhes, Patrick
    Bonnard, Philippe
    Wendum, Dominique
    Molina, Jean-Michel
    Lascoux-Combe, Caroline
    Girard, Pierre-Marie
    JOURNAL OF HEPATOLOGY, 2009, 50 (06) : 1074 - 1083
  • [29] Virological and biochemical evolution of HIV-HBV co-infected patients treated with tenofovir
    Vidiella, G.
    Rios, P.
    Biscayart, C.
    Castillo, S.
    Botas, A.
    Christin, M.
    Stamboulian, D.
    Rodriguez Iantorno, P.
    Vujacich, C.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E403 - E404
  • [30] Liver damage in HIV+HBV co-infected patients determined by transient elastography
    Elena Dumea
    Adrian Streinu-Cercel
    Sorin Rugină
    Lucian Cristian Petcu
    Zizi Niculescu
    Alina Doina Nicoară
    Simona Claudia Cambrea
    BMC Infectious Diseases, 14 (Suppl 4)
12345